Back to Search
TIMOTHY P CRIPE M.D.
M.D.
Pediatric Hematology & Oncology Physician
NPI: 1619907938Individual
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
35-077579(OH)
Research & Publications (20)
Can less really be more? Using lessons from leukemia and cancer stem cells to make sense of oral maintenance for metastatic sarcoma.
PMID 17941067·Pediatr Blood Cancer·2008
6-review
Promoting translational research in academic health centers: navigating the "roadmap".
PMID 16249299·Acad Med·2005
8-other
Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells.
PMID 11306473·Cancer Res·2001
8-other
Exploiting genetic alterations to design novel therapies for cancer.
PMID 11676278·Hematol Oncol Clin North Am·2001
6-review
Overexpression of the cellular DEK protein promotes epithelial transformation in vitro and in vivo.
PMID 19223548·Cancer Res·2009
7-preclinical
Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus.
PMID 19156211·PLoS One·2009
7-preclinical
Prognostic factors and outcomes for osteosarcoma: an international collaboration.
PMID 19349163·Eur J Cancer·2009
8-other
Adenovirus gene therapy for pediatric cancers: shall we gather at the liver?
PMID 19353623·Pediatr Blood Cancer·2009
6-review
Efficacy and safety of the oncolytic herpes simplex virus rRp450 alone and combined with cyclophosphamide.
PMID 18388918·Mol Ther·2008
7-preclinical
Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitors.
PMID 18281493·Cancer Res·2008
7-preclinical
Molecular analysis of human cancer cells infected by an oncolytic HSV-1 reveals multiple upregulated cellular genes and a role for SOCS1 in virus replication.
PMID 18551144·Cancer Gene Ther·2008
4-observational
Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.
PMID 18483311·Mol Cancer Ther·2008
4-observational
Oncolytic HSV and erlotinib inhibit tumor growth and angiogenesis in a novel malignant peripheral nerve sheath tumor xenograft model.
PMID 17235305·Mol Ther·2007
7-preclinical
Adventitious mutations in clinical grade vectors: an issue to consider?
PMID 16595191·Mol Ther·2006
8-other
Malignant peripheral nerve sheath tumors with high and low Ras-GTP are permissive for oncolytic herpes simplex virus mutants.
PMID 16124003·Pediatr Blood Cancer·2006
8-other
Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A.
PMID 16740692·Cancer Res·2006
7-preclinical
The rationale for nonsteroidal anti-inflammatory drug therapy for inflammatory myofibroblastic tumors: a Children's Oncology Group study.
PMID 15991185·J Pediatr Surg·2005
4-observational
Widespread intratumoral virus distribution with fractionated injection enables local control of large human rhabdomyosarcoma xenografts by oncolytic herpes simplex viruses.
PMID 15665822·Cancer Gene Ther·2005
7-preclinical
Oncolytic herpes simplex virus mutants are more efficacious than wild-type adenovirus Type 5 for the treatment of high-risk neuroblastomas in preclinical models.
PMID 15570577·Pediatr Blood Cancer·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 7 locations total
- Address
- 4439 State Route 159
Chillicothe, OH 45601 - Phone
- (614) 722-2000
Locations (7)
Practice Location
4439 State Route 159, Chillicothe, OH
(614) 722-2000
Practice Location
6435 E BROAD ST, COLUMBUS, OH
(614) 722-2000
Practice Location
700 CHILDREN'S DRIVE, COLUMBUS, OH
(614) 722-3552
Practice Location
7853 Pacer Dr, Delaware, OH
(614) 722-2000
Practice Location
5665 Venture Dr, Dublin, OH
(614) 722-2000
Practice Location
536 S Trimble Rd, Mansfield, OH
(614) 722-6200
Practice Location
740 Adair Ave, Zanesville, OH
(614) 722-2000
Quick Facts
- NPI
- 1619907938
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile